Skip to content

Effect of Kinesiology Taping on Head and Trunk Control in Children With Duchenne Muscular Dystrophy

Effect of Kinesiology Taping on Head and Trunk Control in Children With Duchenne Muscular Dystrophy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05967793
Enrollment
30
Registered
2023-08-01
Start date
2023-07-31
Completion date
2023-11-30
Last updated
2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne Muscular Dystrophy

Brief summary

Muscular dystrophy (MD) is a group of muscle diseases that results in increasing weakening and breakdown of skeletal muscles over time. The disorders differ in which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. Many people will eventually become unable to walk. Some types are also associated with problems in other organs. The muscular dystrophy group contains thirty different genetic disorders that are usually classified into nine main categories or types. The signs and symptoms consistent with muscular dystrophy are: progressive muscular wasting, poor balance, scoliosis (curvature of the spine and the back), progressive inability to walk, waddling gait, Calf deformation, Limited range of movement, respiratory difficulty, cardiomyopathy and muscle spasms This study aimed to assess the efficacy of Kinesiology Taping on head and trunk control in patients with Duchenne muscular dystrophy

Detailed description

Duchenne Muscular Dystrophy (DMD) is the most common muscular dystrophy type in childhood. Trunk control is responsible for adaptation during weight transfers, provides and maintains the upright position of the body, organizes postural and correction reactions; and stabilizes the body to perform proximal and distal limb movements, trunk rotations, and making contact between the shoulder and pelvis. In neuromuscular diseases, the trunk is usually ignored both for assessment and treatment as muscle weakness of limbs attracts more attention. Therapists usually focus on activities of lower limb and overhead including standing, walking, climbing, and raising arms to maintain independent mobility in rehabilitation sessions. However, the trunk also gradually gets weaker as the child gets older and this may be associated with movement dysfunction of upper and lower limbs. The Kinesio Taping method is used in the rehabilitation of musculoskeletal disorders, providing either an increase or a decrease in the neural excitation of the muscle, depending on the therapeutic purpose determined after the clinical assessment.

Interventions

OTHERkinesio tape

Kinesio Tape will be applied on paraspinal trunk extensors muscles for 8 weeks, changed every 3 days.

Sponsors

Benha University
CollaboratorOTHER
Egyptian Chinese University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

1. being at the age of 8-12 years 2. being able to cooperate with the instructions of physiotherapist to perform the assessments and procedures.

Exclusion criteria

1. having severe contracture at lower extremities 2. having another neurological and/or musculoskeletal disease diagnosis in addition to DMD. c) having a history of any lower extremity injury or orthopedic/neurologic surgery within the past 6 months.

Design outcomes

Primary

MeasureTime frameDescription
H-reflex latency and amplitude for trunk extensorthrough study completion, an average of 3 monthsH- reflex will be measured by an electromyogram device, four channels electrodiagnostic system with built in amplifier will be used in prone position for levator scapulae muscles and iliocostalis lumborum muscles

Countries

Egypt

Contacts

Primary ContactNoha Elserty, ASS. prof.
noha.serty@fpt.bu.edu.eg01006709648

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026